Stay updated on AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial
Sign up to get notified when there's something new on the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page.

Latest updates to the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.7%
- Check21 days agoChange DetectedThe study now reports an increase in enrollment from 236 to 241 participants, and the treatment period has been updated from 12 weeks to 11 weeks for the randomized groups. Additionally, the results reporting dates have been updated, indicating a more recent timeline for the study's progress.SummaryDifference20%
- Check36 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check64 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check79 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of AVP-786 for treating agitation in Alzheimer's patients, while a new version number has been added.SummaryDifference16%
- Check86 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4 and now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.5%
Stay in the know with updates to AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page.